EHRs could clarify drug safety in pregnant people

Nat Med. 2020 Jun;26(6):820-821. doi: 10.1038/s41591-020-0925-1.

Anup P Challa^{1

2}, Robert R Lavieri³, Ethan S Lippmann⁴, Jeffery A Goldstein⁵, Lisa Bastarache⁶, Jill M Pulley³, David M Aronoff^{7

8

9}

¹ Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN, USA. anup.p.challa.1@vumc.org.
² Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN, USA. anup.p.challa.1@vumc.org.
³ Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN, USA.
⁴ Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN, USA.
⁵ Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
⁶ Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA.
⁷ Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
⁸ Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, TN, USA.
⁹ Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.

No abstract available

MeSH terms